Table 1 The expression of PLAGL2 was correlated with clinicopathological features in PDAC patients.

From: PLAGL2 as a prognostic biomarker and an EMT-promoting factor in PDAC

Clinicopathological features

PLAGL2 expression

P value

High

Low

Age

  

0.566

 < 60

16

14

 

 ≥ 60

20

23

 

Gender*

  

0.044

 Male

12

21

 

 Female

24

16

 

TNM stage*

  

0.023

 I + II

18

28

 

 III + IV

18

9

 

TNM: T*

  

0.002

 T1 + T2

12

26

 

 T3 + T4

24

11

 

TNM: N*

  

0.003

 N0

14

27

 

 N1

22

10

 

TNM: M

 M0

36

37

 

 M1

0

0

 

Tumor size (cm)*

  

0.023

 ≤ 2

5

9

 

 >2

31

28

 

Nerve infiltration*

  

0.019

 No

20

30

 

 Yes

16

7

 

Total bilirubin increased

  

0.279

 Low ≤ 17.1 µmol/L

23

19

 

 High > 17.1 µmol/L

13

18

 

Elevated aminotransferase

  

0.542

 Low ≤ 40 U/L

22

20

 

 High>40 U/L

14

17

 

Differentiation degree

 Well

7

9

 

 Moderate

17

16

 

 Poor

11

6

 

CA199

  

0.401

 Low ≤ 200

22

19

 

 High > 40 U/L

14

18

 
  1. *P < 0.05. Gender, TNM stage, TNM: T, TNM: N, Tumor size (cm), Nerve infiltration.
Back to article page